Residual Disease after Neoadjuvant Therapy for Breast Cancer: Can MRI Help?

被引：8
|
作者：
Hylton, Nola M. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol, 1600 Divisadero St,Room C255, San Francisco, CA 94132 USA
来源：
RADIOLOGY | 2018年 / 289卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1148/radiol.2018181846
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [41] MRI mammography for evaluation of residual disease after excisional biopsy for breast cancer
    Garg, Shubha
    Kumar, Veda Padma Priya Selva
    Kumar, Rajeev
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 125 - 125
  • [42] Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy?
    Nessim, Carolyn
    Trop, Isabelle
    Robidoux, Andre
    Mamounas, Eleftherios P.
    Boileau, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] UTILITY OF MRI AND US FOR EVALUATION OF MINOR RESIDUAL DISEASES AFTER RECEIVING NEOADJUVANT THERAPIES TO BREAST CANCER
    Kido, H.
    Kawawa, Y.
    Manabe, T.
    Nakajima, Y.
    Iwamoto, E.
    Tsuda, H.
    Shimizu, C.
    Kinoshita, T.
    Kusumoto, M.
    Arai, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [44] Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Elder, E. A.
    Livasy, C.
    Donahue, E.
    Neelands, B. J.
    Patrick, A.
    Needham, M.
    Sarantou, T.
    Hadzikadic-Gusic, L.
    White, R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S53 - S53
  • [45] A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+Breast Cancer
    Miglietta, Federica
    Ragazzi, Moira
    Fernandes, Bethania
    Griguolo, Gaia
    Massa, Davide
    Girardi, Fabio
    Bottosso, Michele
    Bisagni, Alessandra
    Zarrilli, Giovanni
    Porra, Francesca
    Iannaccone, Daniela
    Dore, Leocadia
    Gaudio, Mariangela
    Santandrea, Giacomo
    Fassan, Matteo
    Lo Mele, Marcello
    De Sanctis, Rita
    Zambelli, Alberto
    Bisagni, Giancarlo
    Guarneri, Valentina
    Dieci, Maria Vittoria
    CLINICAL CANCER RESEARCH, 2023, 29 (17) : 3429 - 3437
  • [46] New Suspicious Findings at Breast MRI after Neoadjuvant Therapy
    Chang, Amy
    Hayward, Jessica
    RADIOLOGY-IMAGING CANCER, 2023, 5 (06): : e239018
  • [47] Residual Tumor Cellularity Assessment of Breast Cancer After Neoadjuvant Therapy Using Image Transformer
    Hossain, M. D. Shakhawat
    Rahman, MD. Sahilur
    Ahmed, Munim
    Alfaz, Nazia
    Munira Shifat, Sirajum
    Mahbubul Syeed, M. M.
    Hussen, Mohammad Anowar
    Uddin, Mohammad Faisal
    IEEE ACCESS, 2024, 12 : 86083 - 86095
  • [48] Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer
    Peintinger, F.
    Kuerer, H. M.
    McGuire, S. E.
    Bassett, R.
    Pusztai, L.
    Symmans, W. F.
    BRITISH JOURNAL OF SURGERY, 2008, 95 (04) : 433 - 437
  • [49] Accuracy of MRI in predicting pathologic residual disease after neoadjuvant chemotherapy
    Lopez-Yarto, M.
    Vernet-Tomas, M.
    Casas, A.
    Perich, X.
    Junca, V.
    Corominas, J.
    Servitja, S.
    Carreras, R.
    EJC SUPPLEMENTS, 2008, 6 (07): : 130 - 130
  • [50] Surgical strategy after neoadjuvant therapy in patients with operable breast cancer can be optimized by knowledge of the level of agreement of measured tumor size on MRI after neoadjuvant therapy and final pathologic assessment
    Boersma, Catharina
    van Veen, Jannet L. C.
    Maaskant, Jolanda M.
    Van der Starre-Gaal, Jose
    Van 't Veer-Ten Kate, Miranda
    Francken, Anne Brecht
    Noorda, Eva M.
    CANCER RESEARCH, 2018, 78 (04)
12345